TrueBlue (TBI) delivered earnings and revenue surprises of 84.62% and 1.97%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireTACOMA, Wash., Feb. 18, 2025
SIMOS Solutions and Centerline Drivers also receive awards for dedication to client satisfaction TACOMA, Wash., Feb
TMP Worldwide UK, the UK's largest recruitment marketing agency, will provide employer brand and candidate attraction services for the UK's Armed Forces as a d
We recently compiled a list of the 10 Latest AI News and Ratings on Investors' Radar. In this article, we are going to take a look at where TrueBlue, Inc.
For Q3 2024, the Palm Valley Capital Fund declined -0.09% outperforming S&P SmallCap 600 and underperforming the Morningstar Small Cap Total Return Index. Click here to read more.
TrueBlue (TBI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, TrueBlue (TBI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
The mean of analysts' price targets for TrueBlue (TBI) points to a 50.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
TrueBlue (TBI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Overview of the Recent Transaction On September 30, 2024, Invesco Ltd. (Trades, Portfolio), a prominent investment management firm, expanded its portfolio by ac
The average of price targets set by Wall Street analysts indicates a potential upside of 47.1% in TrueBlue (TBI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.